Hill, Holliday Adds Diovan

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

BOSTON Novartis has shifted creative chores on its Diovan hypertension drug to Hill, Holliday, Connors, Cosmopulos from Deutsch without a review, sources said.

Both agencies are units of the Interpublic Group.

Novartis spent more than $350 million so far this year in measured media across all its brands, but has not advertised Diovan in several years, per Nielsen Monitor-Plus. The drug ranks among the nation’s leading hypertension medications with nearly $1.1 billion in overall sales.

Sources said Diovan ad spending could top $75 million in 2007, with work breaking early next year.

The







AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in